Literature DB >> 19451426

Epothilones: better or more of the same?

Paul Sabbatini, David R Spriggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19451426     DOI： 10.1200/JCO.2008.21.6481

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

Authors:  Guillaume Ploussard; Stéphane Terry; Pascale Maillé; Yves Allory; Nanor Sirab; Laurence Kheuang; Pascale Soyeux; Nathalie Nicolaiew; Estelle Coppolani; Bernard Paule; Laurent Salomon; Stéphane Culine; Ralph Buttyan; Francis Vacherot; Alexandre de la Taille
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

Review 2.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

Review 3.  Taccalonolides: Novel microtubule stabilizers with clinical potential.

Authors:  April L Risinger; Susan L Mooberry
Journal:  Cancer Lett       Date:  2009-10-31       Impact factor: 8.679

4.  Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS.

Authors:  Susan M Christner; Robert A Parise; Erica D Levine; Naiyer A Rizvi; Mrinal M Gounder; Jan H Beumer
Journal:  J Pharm Biomed Anal       Date:  2014-08-12       Impact factor: 3.935
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.